Cardiovalve
Cardiovascular Replacement Devices for Minimally Invasive Surgery
Company Overview
Snapshot
Founded in January 2010 by Amir Gross, Cardiovalve operated with 51–200 employees. The company raised $45.48 million across two funding rounds from six investors. Cardiovalve was acquired by Venus Medtech in March 2022.
Business overview
Cardiovalve develops cardiovascular replacement devices for minimally invasive surgery, focusing on solutions for mitral and tricuspid valve conditions. Its flagship system is designed for transfemoral/transseptal delivery, aiming to offer a less invasive alternative to open-heart surgery. The company's technology minimizes protrusion into the left ventricle and interference with cardiac blood flow, enhancing safety and recovery for patients. Cardiovalve operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers and patients.
Strategic signal
In February 2020, Cardiovalve received 'Breakthrough Device Designation' from the FDA for its Transcatheter Tricuspid Valve Replacement System. This designation accelerates the development and review process for medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases, signaling strong regulatory validation and potential for rapid market entry for its innovative technology.
Log in to access full profile ›Company Intelligence Q&A
- What is Cardiovalve's primary focus?
- Cardiovalve focuses on developing cardiovascular replacement devices for minimally invasive surgery, particularly for mitral and tricuspid valve conditions.
- When was Cardiovalve acquired?
- Cardiovalve was acquired by Venus Medtech in March 2022.
- Did Cardiovalve receive any special regulatory designations?
- Yes, in February 2020, Cardiovalve received 'Breakthrough Device Designation' from the FDA for its Transcatheter Tricuspid Valve Replacement System.
- Who are the founders of Cardiovalve?
- Cardiovalve was founded by Amir Gross.
- What was the total capital raised by Cardiovalve?
- Cardiovalve raised a total of $45.48 million across two funding rounds.